These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 13054743

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Urushiol Compounds Detected in Toxicodendron-Labeled Consumer Products Using Mass Spectrometry.
    Zhang AJ, Aschenbeck KA, Law BF, BʼHymer C, Siegel PD, Hylwa SA.
    Dermatitis; 2020; 31(2):134-139. PubMed ID: 32168145
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Evaluation of intramuscular injections of specific extracts in the treatment of acute poison ivy dermatitis.
    HOWELL JB.
    Ann Allergy; 1947; 5(3):219-23. PubMed ID: 20242273
    [No Abstract] [Full Text] [Related]

  • 25. The treatment of acute poison ivy dermatitis with 3-n-pentadecyl catechol by the intradermal route; a preliminary report.
    KEIL H.
    Ann Allergy; 1950; 8(3):356-61. PubMed ID: 15419585
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Poison ivy (Rhus toxicodendron); a survey of the poison ivy problem in Canada and some independent observations on the value of zirconium products in prophylaxis and treatment.
    CASPERS AP.
    Can Med Assoc J; 1957 May 15; 76(10):852-60. PubMed ID: 13426931
    [No Abstract] [Full Text] [Related]

  • 34. Herbarium specimens reveal century-long trait shifts in poison ivy due to anthropogenic CO2 emissions.
    Ng M, McCormick A, Utz RM, Heberling JM.
    Am J Bot; 2023 Sep 15; 110(9):e16225. PubMed ID: 37551738
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Evaluation and Management of Toxicodendron Dermatitis in the Emergency Department: A Review of Current Practices.
    Argo KA, Massey RC, Luth SK, Herrington JM, Lane AQ, Murray KA.
    Wilderness Environ Med; 2023 Sep 15; 34(3):388-392. PubMed ID: 37120383
    [Abstract] [Full Text] [Related]

  • 37. Comparison of the contact allergenicity of the four pentadecylcatechols derived from poison ivy urushiol in human subjects.
    Johnson RA, Haer H, Kirkpatrick CH, Dawson CR, Khurana RG.
    J Allergy Clin Immunol; 1972 Jan 15; 49(1):27-35. PubMed ID: 4257103
    [No Abstract] [Full Text] [Related]

  • 38. Present status of the poison ivy problem.
    MASON HS.
    Ind Hyg Newsl; 1948 Jul 15; 8(7):5. PubMed ID: 18869790
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Peroral prophylaxis of poison ivy dermatitis.
    BESSER JP, URBACH J.
    Ann Allergy; 1952 Jul 15; 10(2):169-71; passim. PubMed ID: 14915361
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.